These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

627 related items for PubMed ID: 27671301

  • 21. Oral delivery of shRNA and siRNA via multifunctional polymeric nanoparticles for synergistic cancer therapy.
    Han L, Tang C, Yin C.
    Biomaterials; 2014 May; 35(15):4589-600. PubMed ID: 24613049
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of RhoA expression by adenovirus-mediated siRNA combined with TNF-α induced apoptosis of hepatocarcinoma cells.
    Yin K, Zhao G, Huang X, Gao G, Sun H, Wei Q, Liu Q, Li M, Xu C, Zhu S, Ba Z, Yan G.
    Biomed Mater Eng; 2015 May; 26 Suppl 1():S2055-67. PubMed ID: 26405983
    [Abstract] [Full Text] [Related]

  • 23. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J, Farzan M.
    World J Gastroenterol; 2015 Nov 14; 21(42):12022-41. PubMed ID: 26576089
    [Abstract] [Full Text] [Related]

  • 24. Effect of PAK1 gene silencing on proliferation and apoptosis in hepatocellular carcinoma cell lines MHCC97-H and HepG2 and cells in xenograft tumor.
    Zhang ZL, Liu GC, Peng L, Zhang C, Jia YM, Yang WH, Mao L.
    Gene Ther; 2018 Jul 14; 25(4):284-296. PubMed ID: 29802374
    [Abstract] [Full Text] [Related]

  • 25. Lentiviral-Mediated Short Hairpin RNA Knockdown of MTDH Inhibits Cell Growth and Induces Apoptosis by Regulating the PTEN/AKT Pathway in Hepatocellular Carcinoma.
    Li WF, Ou Q, Dai H, Liu CA.
    Int J Mol Sci; 2015 Aug 17; 16(8):19419-32. PubMed ID: 26287185
    [Abstract] [Full Text] [Related]

  • 26. Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma.
    Pellegrino R, Calvisi DF, Ladu S, Ehemann V, Staniscia T, Evert M, Dombrowski F, Schirmacher P, Longerich T.
    Hepatology; 2010 Mar 17; 51(3):857-68. PubMed ID: 20112253
    [Abstract] [Full Text] [Related]

  • 27. Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells.
    Yi Y, Kim HJ, Zheng M, Mi P, Naito M, Kim BS, Min HS, Hayashi K, Perche F, Toh K, Liu X, Mochida Y, Kinoh H, Cabral H, Miyata K, Kataoka K.
    J Control Release; 2019 Feb 10; 295():268-277. PubMed ID: 30639386
    [Abstract] [Full Text] [Related]

  • 28. Novel oncolytic adenovirus selectively targets tumor-associated polo-like kinase 1 and tumor cell viability.
    Zhou J, Gao Q, Chen G, Huang X, Lu Y, Li K, Xie D, Zhuang L, Deng J, Ma D.
    Clin Cancer Res; 2005 Dec 01; 11(23):8431-40. PubMed ID: 16322306
    [Abstract] [Full Text] [Related]

  • 29. Combined gene expression profiling and RNAi screening in clear cell renal cell carcinoma identify PLK1 and other therapeutic kinase targets.
    Ding Y, Huang D, Zhang Z, Smith J, Petillo D, Looyenga BD, Feenstra K, Mackeigan JP, Furge KA, Teh BT.
    Cancer Res; 2011 Aug 01; 71(15):5225-34. PubMed ID: 21642374
    [Abstract] [Full Text] [Related]

  • 30. Enhanced chemosensitivity to CPT-11 in colorectal carcinoma xenografts by small hairpin RNA interference targeting PLK1.
    Fan P, Zhang S, Tian H, Yan N, Dai L, Zhang X, Cheng L, Li C, Li Y, Chen X, Shi G, Yang Y, Wei Y, Deng H.
    Neoplasma; 2012 Aug 01; 59(6):676-84. PubMed ID: 22862168
    [Abstract] [Full Text] [Related]

  • 31. Combination of Nanoparticle-Delivered siRNA for Astrocyte Elevated Gene-1 (AEG-1) and All-trans Retinoic Acid (ATRA): An Effective Therapeutic Strategy for Hepatocellular Carcinoma (HCC).
    Rajasekaran D, Srivastava J, Ebeid K, Gredler R, Akiel M, Jariwala N, Robertson CL, Shen XN, Siddiq A, Fisher PB, Salem AK, Sarkar D.
    Bioconjug Chem; 2015 Aug 19; 26(8):1651-61. PubMed ID: 26079152
    [Abstract] [Full Text] [Related]

  • 32. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1.
    Mao Y, Xi L, Li Q, Cai Z, Lai Y, Zhang X, Yu C.
    Oncol Rep; 2016 Jul 19; 36(1):49-56. PubMed ID: 27220401
    [Abstract] [Full Text] [Related]

  • 33. Targeting HSP60 by subcutaneous injections of jetPEI/HSP60-shRNA destabilizes cytoplasmic survivin and inhibits hepatocellular carcinoma growth.
    Huang YH, Lin KH, Yu JS, Wu TJ, Lee WC, Chao CC, Pan TL, Yeh CT.
    Mol Carcinog; 2018 Sep 19; 57(9):1087-1101. PubMed ID: 29672920
    [Abstract] [Full Text] [Related]

  • 34. Nitidine chloride induces apoptosis in human hepatocellular carcinoma cells through a pathway involving p53, p21, Bax and Bcl-2.
    Ou X, Lu Y, Liao L, Li D, Liu L, Liu H, Xu H.
    Oncol Rep; 2015 Mar 19; 33(3):1264-74. PubMed ID: 25530218
    [Abstract] [Full Text] [Related]

  • 35. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.
    Wang J, Xia C, Pu M, Dai B, Yang X, Shang R, Yang Z, Zhang R, Tao K, Dou K.
    Oncol Rep; 2018 Oct 19; 40(4):1875-1884. PubMed ID: 30015982
    [Abstract] [Full Text] [Related]

  • 36. Effects of Cationic Microbubble Carrying CD/TK Double Suicide Gene and αVβ3 Integrin Antibody in Human Hepatocellular Carcinoma HepG2 Cells.
    Li J, Zhou P, Li L, Zhang Y, Shao Y, Tang L, Tian S.
    PLoS One; 2016 Oct 19; 11(7):e0158592. PubMed ID: 27391603
    [Abstract] [Full Text] [Related]

  • 37. Reduced efficacy of the Plk1 inhibitor BI 2536 on the progression of hepatocellular carcinoma due to low intratumoral drug levels.
    Haupenthal J, Bihrer V, Korkusuz H, Kollmar O, Schmithals C, Kriener S, Engels K, Pleli T, Benz A, Canamero M, Longerich T, Kronenberger B, Richter S, Waidmann O, Vogl TJ, Zeuzem S, Piiper A.
    Neoplasia; 2012 May 19; 14(5):410-9. PubMed ID: 22745587
    [Abstract] [Full Text] [Related]

  • 38. Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells.
    Bu Y, Yang Z, Li Q, Song F.
    Oncology; 2008 May 19; 74(3-4):198-206. PubMed ID: 18714168
    [Abstract] [Full Text] [Related]

  • 39. pH-responsive hybrid nanoparticle with enhanced dissociation characteristic for siRNA delivery.
    Shi M, Zhao X, Zhang J, Pan S, Yang C, Wei Y, Hu H, Qiao M, Chen D, Zhao X.
    Int J Nanomedicine; 2018 May 19; 13():6885-6902. PubMed ID: 30498349
    [Abstract] [Full Text] [Related]

  • 40. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
    Zhang DM, Liu JS, Deng LJ, Chen MF, Yiu A, Cao HH, Tian HY, Fung KP, Kurihara H, Pan JX, Ye WC.
    Carcinogenesis; 2013 Jun 19; 34(6):1331-42. PubMed ID: 23393227
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.